71 institutions hold shares in BELLUS Health Inc. (BLU), with 17.19M shares held by insiders accounting for 21.94% while institutional investors hold 60.83% of the company’s shares. The shares outstanding are 60.45M, and float is at 40.20M with Short Float at 3.66%. Institutions hold 47.48% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is Orbimed Advisors LLC. with over 5.14 million shares valued at $11.66 million. The investor’s holdings represent 6.56% of the BLU Shares outstanding. As of Sep 29, 2020, the second largest holder is RTW Investments LP with 4.2 million shares valued at $9.52 million to account for 5.36% of the shares outstanding. The other top investors are Polar Capital LLP which holds 3.0 million shares representing 3.83% and valued at over $6.81 million, while Boxer Capital, LLC holds 3.80% of the shares totaling 2.98 million with a market value of $6.75 million.
BELLUS Health Inc. (NASDAQ: BLU) is 36.93% higher on its value in year-to-date trading and has touched a low of $2.01 and a high of $12.03 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BLU stock was last observed hovering at around $4.56 in the last trading session, with the day’s loss setting it -0.37% off its average median price target of $8.00 for the next 12 months. It is also 65.08% off the consensus price target high of $12.00 offered by 8 analysts, but current levels are -61.15% lower than the price target low of $2.60 for the same period.
Currently trading at $4.19, the stock is 12.03% and 22.16% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.45 million and changing -8.11% at the moment leaves the stock -4.65% off its SMA200. BLU registered -60.66% loss for a year compared to 6-month gain of 56.93%. The firm has a 50-day simple moving average (SMA 50) of $3.6236 and a 200-day simple moving average (SMA200) of $2.8580.
The stock witnessed a 6.62% loss in the last 1 month and extending the period to 3 months gives it a 36.04%, and is 11.44% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.86% over the week and 9.22% over the month.
BELLUS Health Inc. (BLU) has around 17 employees, a market worth around $303.23M and $0.02M in sales. Distance from 52-week low is 108.46% and -65.17% from its 52-week high.
BELLUS Health Inc. (BLU) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for BELLUS Health Inc. (BLU) is a “Overweight”. 8 analysts offering their recommendations for the stock, where 2 rate it as a Hold and 0 think it is a “Overweight”. 6 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
BELLUS Health Inc. is expected to release its quarterly report on 05/18/2021.The EPS is expected to shrink by -168.90% this year.